Court of Justice (First Chamber) 13 March 2014, C‑512/12 (Octapharma France SAS v Agence nationale de sécurité du médicament et des produits de santé (ANSM) and Ministère des Affaires sociales et de la Santé.)

JUDGMENT OF THE COURT (First Chamber) 13 March 2014 ( *1 ) ‛Approximation of laws — Directive 2001/83/EC — Directive 2002/98/EC — Scope — Labile blood product — Plasma prepared by means of an industrial process — Simultaneous or exclusive application of the directives — Option for a Member State to provide for a more rigorous regime for plasma than for medicinal products’ In Case C‑512/12,